Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Up to $[**] [**] % >$[**] to $[**] [**] % >$[**] [**] %
Appears in 4 contracts
Samples: License and Commercialization Agreement (Bellerophon Therapeutics LLC), License and Commercialization Agreement (Bellerophon Therapeutics LLC), License and Commercialization Agreement (Ikaria, Inc.)
Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Up to $[***] [**] % >$[**] to $[**] [**] % >$[**] [**] %]
Appears in 2 contracts
Samples: License and Commercialization Agreement (BioLineRx Ltd.), License and Commercialization Agreement (BioLineRx Ltd.)
Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Up to $[**] [**] 250 Million 11 % >$[**] 250 Million to $[**] [**] 1 Billion 13 % >$[**] [**] 1 Billion 15 %
Appears in 1 contract
Samples: License and Commercialization Agreement (Bellerophon Therapeutics, Inc.)
Royalties on Net Sales of Products. During the Royalty Term applicable to each Product, and subject to adjustment as set forth in Section 4.2(b), Ikaria shall pay to BioLineRx royalties on a Product-by-Product basis, with the amount of such royalties calculated as a percentage of Net Sales in a calendar year for such Product as set forth below: Up to $[***] [**] % >$[**] to $[**] [**] % >$[**] [**] %]
Appears in 1 contract
Samples: License and Commercialization Agreement (BioLineRx Ltd.)